Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Feb 13, 2024

SELL
$0.39 - $1.23 $5,850 - $18,450
-15,000 Closed
0 $0
Q4 2021

Feb 13, 2024

BUY
$0.98 - $1.86 $14,700 - $27,900
15,000 New
15,000 $14.8 Million

Others Institutions Holding CYDY

About CytoDyn Inc.


  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $89.4M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track United Community Bank Portfolio

Follow United Community Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Community Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Community Bank with notifications on news.